ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tanshinone IIA Alleviates Atherosclerosis Through Inhibition of NF-κB and PPARαE/ABCA1 Signaling Pathways

He, Dequan; Zhang, Jiawei; Chen, Youquan; Li, Zhiliang*广州医学院; 南方医科大学
Journal of Biomedical Nanotechnology2023-10DOI: 10.1166/jbn.2023.3689
22阅读
引用收藏
分享

摘要

This study evaluated the role and underlying mechanisms of Tanshinone IIA (Tan IIA) in atherosclerosis. C57BL mice (control group) and ApoE mice (model group) were administered a conventional and high-fat diet for 20 weeks. The Tan IIA group was obtained by administering a high-fat diet plus 8 weeks of Tan IIA to other mice for 20 weeks, followed by oil red O staining and lipid examination. RAW264.7 cells were transfected with PPAR alpha siRNA+Tan IIA to measure their expression. The results showed little change in body weight between the three groups (P < 0.05). Liver index was significantly increased in the model and Tan IIA groups (P <0.05). Atherosclerotic plaques, plaque cross-sectional area, human oxidized low-density lipoprotein (ox-LDL), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) levels, p-NF-kappa B, p-IKK alpha, P-Ikk alpha/beta, TNF-alpha and IL-1 beta levels were significantly increased in the model group and decreased in the Tan IIA group (P < 0.05). We also noted a decrease in PPAR alpha, PGC-1 alpha and ABCA1 in the model group and an increase in the Tan IIA group. NF-kappa B expression was increased in the nucleus and decreased in the cytoplasm in the model group, which was reversed by Tan IIA treatment. Tan IIA significantly reduced ox-LDL, LDL-C and TG levels, plaque size and plaque cross-sectional area in atherosclerosis. Tan IIA effectively inhibited NF-kappa B, activated the PPAR alpha/ABCA1 signalling pathway, and reduce inflammatory pathways, thereby improving lipid deposition and acting as an anti-atherosclerotic agent.

学科与关键词

关键词
Tanshinone IIANF-kappa BPPAR alpha/ABCA1Inflammatory ResponseLipid DepositionAtherosclerosis Tanshinone IIAAtherosclerosis
相关
加载中…
  • Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis
    Xu, Lianjie; Liu, Xiao; Jia, Tao; Sun, Yanhong; Du, Yan; Wei, Shanshan; Wang, Wei; Zhang, Yurong; Chen, Wenhui; Zhang, Shan*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5769350.被引 6
  • Tanshinone IIA Regulates Keap1/Nrf2 Signal Pathway by Activating Sestrin2 to Restrain Pulmonary Fibrosis
    Li, Hongxia; Wu, Mingyu; Guo, Congying; Zhai, Rao; Chen, Jun*AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50(8): 2125-2151.被引 14
  • Tanshinone IIA regulates the TGF-&beta;1/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis
    Xu, Lianjie; Zhang, Yurong; Ji, Nengbo; Du, Yan; Jia, Tao; Wei, Shanshan; Wang, Wei; Zhang, Shan*; Chen, Wenhui*Experimental and Therapeutic Medicine, 2022, 24(1).被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Biomedical Nanotechnology
发表日期
2023-10
卷期
第 19 卷, 第 10 期
页码
1824-1831
DOI
10.1166/jbn.2023.3689
语言
ENGLISH
成果收录
SCIE

作者

  • H

    He, Dequan (第一作者)

    southern med univ

  • Z

    Zhang, Jiawei

    guangzhou med univ

查看全部 4 位作者收起作者
  • C

    Chen, Youquan

    guangzhou med univ

  • L

    Li, Zhiliang (通讯)

    shenzhen univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417